Tang Capital Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Hold |
1,050,000
| – | – | 0.97% | 32 |
|
|
2025
Q1 | $20.8M | Buy |
1,050,000
+500,000
| +91% | +$9.92M | 1.15% | 24 |
|
|
2024
Q4 | $9.43M | Buy |
+550,000
| New | +$9.43M | 0.62% | 45 |
|
|
2024
Q1 | – | Sell |
-1,360,000
| Closed | -$6.15M | – | 101 |
|
|
2023
Q4 | $6.15M | Hold |
1,360,000
| – | – | 0.57% | 43 |
|
|
2023
Q3 | $4.87M | Buy |
1,360,000
+100,000
| +8% | +$358K | 0.69% | 44 |
|
|
2023
Q2 | $4.65M | Buy |
+1,260,000
| New | +$4.65M | 0.68% | 38 |
|
|
2022
Q4 | – | Sell |
-992,840
| Closed | -$2.41M | – | 90 |
|
|
2022
Q3 | $2.41M | Buy |
+992,840
| New | +$2.41M | 0.3% | 67 |
|